AI-CVD vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung AI
VS
by Imbio

AI Verdict

AI-CVD is a comprehensive platform for opportunistic screening of various cardiovascular and multisystem diseases, providing broad measurements including CAC scoring and cardiac chamber volumetry. In contrast, Imbio RV/LV Software is a specialized tool focused on calculating the RV/LV ratio from CTPA scans to aid in risk stratification for pulmonary conditions like pulmonary embolism. While both leverage AI for cardiac analysis on CT scans, their primary clinical applications and feature sets cater to different diagnostic needs.

Choose AI-CVD if…

Choose AI-CVD if your primary goal is broad, opportunistic screening for a wide range of cardiovascular and multisystem disease risks using existing CT scans. This tool is ideal for identifying hidden health risks and enabling early detection without requiring additional imaging, radiation, or workflow disruption, leveraging scans already performed for other indications.

View AI-CVD →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if you need a specialized, automated tool for rapid risk stratification in patients with suspected pulmonary conditions, particularly pulmonary embolism. This software excels at precisely measuring right and left ventricular diameters from CTPA scans and calculating the RV/LV ratio to inform clinical decisions in acute settings.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD Imbio RV/LV Software
Deployment Unknown Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]
FDA Status Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize fully automated workflows and seamless integration into existing clinical environments. AI-CVD highlights 'no workflow disruption' and patient-friendly reports, while Imbio RV/LV Software explicitly mentions DICOM compliance, PACS integration, and no user intervention after scan completion.

Clinical Value

AI-CVD

AI-CVD offers broader clinical value by performing opportunistic screening for a wide range of cardiovascular and multisystem diseases, including coronary heart disease, heart failure, stroke, osteoporosis, and liver steatosis, from existing CT scans. In contrast, Imbio RV/LV Software is more narrowly focused on measuring RV/LV ratios for risk stratification in pulmonary conditions like pulmonary embolism.

Pricing & Value

Imbio RV/LV Software

Imbio RV/LV Software offers a more transparent, subscription-based pricing model tied to the number of analyses or installations, which is generally preferred by institutions for predictable budgeting and scalable use. AI-CVD requires contacting the vendor for pricing, which is less transparent, although it has a new CMS reimbursement code for some of its features.

Enterprise Readiness

Imbio RV/LV Software

Imbio RV/LV Software demonstrates superior enterprise readiness with explicit third-party HIPAA compliance certification and a wider range of deployment options, including cloud, on-premise, and integration with numerous partner platforms. AI-CVD's compliance and BAA are only 'likely' and require direct vendor contact for confirmation.

Innovation

AI-CVD

AI-CVD presents a more innovative approach by offering comprehensive opportunistic screening for a wide range of cardiovascular and multisystem diseases from existing CT scans, enabling early detection of hidden health risks without additional procedures. Imbio RV/LV Software's innovation is primarily in the automation and accuracy of a specific, albeit important, measurement for pulmonary embolism risk stratification.

Support & Docs

Imbio RV/LV Software

Imbio RV/LV Software provides clear support channels, including phone and email, and explicitly states the availability of user manuals and product documentation, with some manuals publicly accessible. Information regarding support and documentation for AI-CVD is not readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD Imbio RV/LV Software
Name AI-CVD Imbio RV/LV Software
Company HeartLung Corporation Imbio
Key Features Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing Automated measurement of right and left ventricular diameters, Calculation and reporting of RV/LV ratio, Artificial intelligence algorithm for ventricle identification and measurement, Provides annotated images showing ventricular measurements, Generates summary PDF reports, Fully automated workflow, no user intervention required after scan completion, DICOM compliant input and output, Integration with standard reading environments (PACS)
Specialties Cardiology, Pulmonology, Radiology Cardiology, Pulmonology, Radiology
Categories Cardiology AI Cardiology AI, Radiology & Imaging AI

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Imbio RV/LV Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVDu00ae is designed for opportunistic screening using existing chest and abdominal CT scans. Imbio RV/LV Software specifically utilizes CTPA (Computed Tomography Pulmonary Angiography) scans to perform its analysis.
AI-CVDu00ae offers a broad range of measurements including Coronary Artery Calcium (CAC) scoring, aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. Imbio RV/LV Software focuses on automated measurement of right and left ventricular diameters and the calculation and reporting of the RV/LV ratio.
AI-CVDu00ae is intended for opportunistic screening and early detection of hidden health risks related to cardiovascular and multisystem diseases. Imbio RV/LV Software aids in risk stratification for pulmonary conditions, such as pulmonary embolism, by providing the RV/LV ratio.
AI-CVDu00ae is designed to integrate without additional imaging, radiation, contrast, or workflow disruption, leveraging existing CT scans. Imbio RV/LV Software features a fully automated workflow requiring no user intervention after scan completion, is DICOM compliant, and integrates with standard reading environments like PACS.
AI Tool Finder
AI-powered search. Results may not be comprehensive.